ProCE Banner Activity

JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making

Slideset Download

Hear from the experts as they highlight the latest clinical trial and real-world evidence regarding JAK inhibitor efficacy and safety to help contextualize risks and apply practical mitigation strategies to comprehensive care plans.

Released: January 09, 2023

Expiration: January 08, 2024

No longer available for credit.

Share

Faculty

Vivian P. Bykerk

Vivian P. Bykerk, MD, FRCPC

Director
Inflammatory Arthritis Center of Excellence
Rheumatology Attending
Department of Rheumatology
Hospital for Special Surgery
Professor of Medicine
Division of Rheumatology
Department of Medicine
Weill Cornell Medical Center
New York, New York

Stanley B. Cohen

Stanley B. Cohen, MD

Clinical Professor
Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director
Division of Rheumatology
Presbyterian Hospital
Dallas, Texas

Janet Pope

Janet Pope

Professor of Medicine
Division of Rheumatology
Division of Epidemiology and Biostatistics
University of Western Ontario Schulich School of Medicine
Division Head
Rheumatology
St. Joseph’s Health Centre
London, Ontario, Canada

Vibeke Strand

Vibeke Strand, MD, MACR, FACP

Adjunct Clinical Professor
Division of Immunology/Rheumatology
Stanford University
Biopharmaceutical Consultant
Palo Alto, California

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Lilly

Faculty Disclosure

Primary Author

Vivian P. Bykerk, MD, FRCPC

Director
Inflammatory Arthritis Center of Excellence
Rheumatology Attending
Department of Rheumatology
Hospital for Special Surgery
Professor of Medicine
Division of Rheumatology
Department of Medicine
Weill Cornell Medical Center
New York, New York

Stanley B. Cohen, MD

Clinical Professor
Department of Internal Medicine
University of Texas Southwestern Medical School
Co-Director
Division of Rheumatology
Presbyterian Hospital
Dallas, Texas

Janet Pope,

Professor of Medicine
Division of Rheumatology
Division of Epidemiology and Biostatistics
University of Western Ontario Schulich School of Medicine
Division Head
Rheumatology
St. Joseph’s Health Centre
London, Ontario, Canada

Vibeke Strand, MD, MACR, FACP

Adjunct Clinical Professor
Division of Immunology/Rheumatology
Stanford University
Biopharmaceutical Consultant
Palo Alto, California